The QuikClot Control+™ Hemostatic Device is now indicated for temporary control of external and identifiable sites of internal mild, moderate, severe, and life-threatening bleeding in the United ...

Teleflex (NYSE: TFX) + announced today that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device. The expanded indications now include all grades of ...

Baxter launches the Hemopatch Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing. Baxter International Inc. (NYSE: BAX), a renowned leader in pioneering surgical ...